alfuzosin vs vibegron
Side-by-side comparison of alfuzosin and vibegron Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Alfuzosin is a medicine that helps men with enlarged prostate glands. It relaxes the muscles in the prostate and bladder, making it easier to urinate.
Gemtesa is a medicine that helps control an overactive bladder. It relaxes the bladder muscle, so you don't have to go to the bathroom as often.
This medicine treats the symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. BPH can cause problems with urination, such as difficulty starting or stopping, frequent urination, and feeling like you can't empty your bladder. Alfuzosin helps to improve these symptoms.
Gemtesa treats overactive bladder (OAB) in adults. OAB can cause you to feel a sudden need to pee (urgency). It can also cause you to pee more often (frequency) or leak urine (urge urinary incontinence). Gemtesa can also treat these symptoms in men who are taking medicine for an enlarged prostate (benign prostatic hyperplasia or BPH).
Alfuzosin belongs to a class of drugs called alpha-1 blockers. It works by relaxing the muscles in the prostate and bladder neck. This relaxation allows urine to flow more freely, relieving the symptoms of BPH.
Gemtesa is a beta-3 adrenergic agonist. It works by relaxing the bladder muscle. This helps to increase the bladder's capacity to hold urine and reduces the urge to go.
- • Dizziness
- • Upper respiratory tract infection
- • Headache
- • Fatigue
- • Headache
- • Urinary tract infection
- • Runny or stuffy nose
- • Diarrhea
- • Nausea
- The medicine is not working 112
- Using the medicine for something it's not approved for 96
- Difficulty breathing 89
- The medicine is interacting with another medicine 87
- Tiredness 87
- The medicine is not working 886
- Diarrhea 328
- Headache 328
- Urinary tract infection 280
- Cannot afford the medicine 265
Alfuzosin can cause your blood pressure to drop suddenly when you stand up, leading to dizziness or fainting. Be careful when standing up quickly, especially when you first start taking this medicine. If you have chest pain (angina), tell your doctor immediately. This medicine may also affect your heart rhythm. Tell your doctor if you have a history of heart problems.
Gemtesa can cause urinary retention, which means you can't empty your bladder fully. Tell your doctor if you have trouble emptying your bladder or are taking other medicines for OAB. Angioedema (swelling of the face, tongue, or throat) has been reported with Gemtesa. If this happens, stop taking Gemtesa and get medical help right away.
This medicine is only for men and is not intended for use in women. It is not known if alfuzosin can harm an unborn baby or pass into breast milk.
There is not enough information about using Gemtesa during pregnancy to know if it is safe. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Also Compare — Nearby Drugs
Compare vibegron with
How to Read This alfuzosin vs vibegron Comparison
alfuzosin is classified in the Alpha-1 Blocker (BPH) drug class, while vibegron sits within the Beta-3 Agonist (Overactive Bladder) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, alfuzosin has 471 submissions while vibegron has 2,087. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between alfuzosin and vibegron — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.